المؤلفون: Camilla B. Jensen, Sayeh Tadayon, Step Investigators, Niclas Abrahamsson, Dror Dicker, Frank L. Greenway, Dan Hesse, Gottfried Rudofsky, Melanie J. Davies, Julio Rosenstock, Ildiko Lingvay, Miguel A. Rubio, Thomas A. Wadden, Domenica Rubino, Ofri Mosenzon

المصدر: Rubino, D, Abrahamsson, N, Davies, M, Hesse, D, Greenway, F L, Jensen, C, Lingvay, I, Mosenzon, O, Rosenstock, J, Rubio, M A, Rudofsky, G, Tadayon, S, Wadden, T A, Dicker, D, Sjödin, A M & STEP 4 Investigators 2021, ' Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 Randomized Clinical Trial ', JAMA, vol. 325, no. 14, pp. 1414-1425 . https://doi.org/10.1001/jama.2021.3224

مصطلحات موضوعية: Adult, Glucagon-Like Peptides/adverse effects, Male, medicine.medical_specialty, Obesity/drug therapy, Injections, Subcutaneous, Weight Loss/drug effects, Glucagon-Like Peptides, Blood Pressure, Overweight, Placebo, Blood Pressure/drug effects, law.invention, Waist Circumference/drug effects, Randomized controlled trial, Double-Blind Method, law, Weight loss, Glucagon-Like Peptide 1, Internal medicine, Weight Loss, medicine, Clinical endpoint, Anti-Obesity Agents/pharmacology, Humans, Overweight/drug therapy, Obesity, Maintenance dose, business.industry, Semaglutide, General Medicine, Middle Aged, Female, Anti-Obesity Agents, medicine.symptom, Waist Circumference, business, Glucagon-Like Peptide 1/agonists, Body mass index

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17ccf01a3b9760235ac5622c17a335a1
https://curis.ku.dk/ws/files/291012447/Rubino_et_al_JAMA_2021_Vol_325_14_1414_1425.pdf